Allergan Launches 2nd Suit Over Combigan Patents

Law360, New York (June 8, 2009, 12:00 AM EDT) -- Allergan Inc. has accused Hi-Tech Pharmacal Co. Inc. of infringing two patents for Combigan, marking the second time in less than two months the drug manufacturer has moved to block a generics maker from selling its own version of the glaucoma treatment.

The complaint, filed Friday in the U.S. District Court for the Eastern District of Texas, takes aim at an abbreviated new drug application that Hi-Tech submitted to the U.S. Food and Drug Administration in a bid to market a generic copy of Combigan before...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.